Two in Three Are Concerned That Restrictions on Medication Abortion Would Insert Politicians And Courts Into Personal Decisions

September 25, 2024
Rachael Russell

Polling data on the latest attacks on abortion medication, including the most concerning aspects of restricting access to FDA-approved medication.

Poll: Medication Abortion

This Navigator Research report contains polling data on perceptions of the latest attacks on abortion medication, including the most concerning aspects of restricting access to FDA-approved abortion medication.

Three in five Americans agree that patients deserve access to abortion medication through telehealth and the mail.


By a 33-point margin, Americans overwhelmingly agree more with those who say “patients deserve access to safe, effective, FDA-approved medication, including abortion medication, through telehealth and the mail” (58 percent) over those who say “we need to ban distributing abortion medication by mail to protect the lives of unborn children and stop on-demand abortions” (25 percent). Four in five Democrats (79 percent), a majority of independents (55 percent), and over a third of Republicans (35 percent) agree patients deserve access to abortion medication. 17 percent say they are not sure which they agree with most, including 30 percent of independents and 20 percent of Republicans.

A majority of Americans who believe abortion should only be legal sometimes (either legal with some restrictions or illegal with some exceptions) also agree that Americans deserve access to abortion medication (net +28; 55 percent deserve access – 27 percent ban abortion). 

62 percent of Americans support allowing women to legally use prescription abortion medication to end an early pregnancy at home, including 81 percent of Democrats and 54 percent of independents. Republicans are narrowly divided by a 3-point margin (42 percent support – 45 percent oppose). 

By an 18-point margin, Americans view early abortion medication favorably (47 percent favorable – 29 percent unfavorable), including two in three Democrats (67 percent) and a plurality of independents (41 percent). Just 22 percent are familiar with Mifepristone (14 percent favorable – 9 percent unfavorable), with Democrats most familiar (29 percent), compared to just 12 percent of independents and 18 percent of Republicans.

Bar graph of polling data from Navigator Research. Title: Nearly Three in Five Say Patients Deserve Access to Abortion Medication Through Telehealth and the Mail
Bar graph of polling data from Navigator Research. Title: Majorities Continue to Support Prescription Abortion Medication Used At Home to End an Early Pregnancy
Bar graph of polling data from Navigator Research. Title: Mifepristone Is Mostly Unknown, While Views On Early Abortion Medication Are in the Positive

Two in three Americans are concerned that restrictions on abortion medication would insert politicians and courts into decisions that should be made by women and doctors.


Two in three Americans are concerned that restrictions on abortion medication would insert politicians and courts into decisions that should be made by women and doctors. Among a list of statements about restricting the distribution of FDA-approved abortion medication, at least two in three Americans were concerned by the following:

These restrictions would insert politicians and courts into a decision that should be made by women and their doctors (67 percent find this concerning, including 68 percent of those who believe abortion should only be legal sometimes);

Women and families across the country will almost entirely lose access to FDA-approved medication used to end a pregnancy if these restrictions are put in place (67 percent find this concerning, including 64 percent of those who believe abortion should only be legal sometimes); 

Because they undermine the FDA’s ability to approve medication, these restrictions open the door to every state setting up their own FDA, putting politicians further in charge of our personal healthcare decisions (66 percent find this concerning, including 64 percent of those who believe abortion should only be legal sometimes); and,

Because they undermine the FDA’s ability to approve medication, these restrictions would put access to other FDA-approved medications at risk no matter what state you live in (66 percent find this concerning, including 64 percent of those who believe abortion should only be legal sometimes).

Bar graph of polling data from Navigator Research. Title: A Range of Messages About GOP Restrictions Are Concerning

Read More

January 29, 2026

Meet The Pocketbook Pessimists

This Navigator Research report covers Americans who rate the economy negatively or are unsure but don’t yet blame Trump and Republicans in Congress.

Julie Alderman Boudreau
January 27, 2026

ICE’s Aggression is Fracturing Republicans

Polling report on shifting public sentiment on immigration, Trump’s handling of immigration and deportations, and the deployment of ICE.

Maryann Cousens & Julie Alderman Boudreau
January 21, 2026

Focus Group Report: Trump Regrets … They’ve Had A Few

Focus group report on Americans in battleground states who voted for Trump in 2024 and expressed regret or misgivings about their vote.

Julie Alderman Boudreau
January 20, 2026

One Year In: Americans Give Trump a C- Grade

Polling report on the latest views of President Trump’s first year in office, including how Americans think his policies have impacted the country, and how they would rate his performance as President.

Maryann Cousens & Julie Alderman Boudreau
Share

About The Study

Global Strategy Group conducted a public opinion survey among a sample of 1,003 registered voters from September 12-September 16, 2024. 106 additional interviews were conducted among Hispanic voters. 76 additional interviews were conducted among Asian American and Pacific Islander voters. 100 additional interviews were conducted among African American voters. 106 additional interviews were conducted among independent voters. The survey was conducted online, recruiting respondents from an opt-in online panel vendor. Respondents were verified against a voter file and special care was taken to ensure the demographic composition of our sample matched that of the national registered voter population across a variety of demographic variables. The margin of error for the full sample at the 95 percent level of confidence is +/- 3.1 percentage points. The margin of error for subgroups varies and is higher.